Advertisement
Research ArticlePerspectives in Pharmacology

Pharmacology at Work for Cardio-Oncology: Ranolazine to Treat Early Cardiotoxicity Induced by Antitumor Drugs

Giorgio Minotti
Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 343-349; DOI: https://doi.org/10.1124/jpet.113.204057

Article Information

vol. 346 no. 3 343-349
DOI 
https://doi.org/10.1124/jpet.113.204057
PubMed 
23818683
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received April 5, 2013
  • Accepted June 27, 2013
  • Published online August 15, 2013.

Article Versions

Copyright & Usage 
Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Giorgio Minotti
  1. CIR and Drug Sciences, University Campus Bio-Medico, Rome, Italy
  1. Address correspondence to:
    Giorgio Minotti, CIR and Drug Sciences, University Campus Bio-Medico, Via Alvaro del Portillo, 21, 00128 Rome, Italy. E-mail: g.minotti{at}unicampus.it
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2013 to December 2024

AbstractFullPdf
Jul 20133100207
Aug 20136471994
Sep 20135692353
Oct 2013117723
Nov 2013783256
Dec 2013921521
Jan 2014471420
Feb 2014681623
Mar 201461824
Apr 2014511022
May 2014421421
Jun 201425610
Jul 20142937
Aug 20142827
Sep 2014232125
Oct 2014365351
Nov 2014263129
Dec 2014351817
Jan 2015353129
Feb 2015282826
Mar 2015263922
Apr 2015162328
May 2015244965
Jun 2015132337
Jul 201592236
Aug 2015222021
Sep 2015212846
Oct 2015121622
Nov 201582315
Dec 2015171715
Jan 2016143020
Feb 201692724
Mar 2016202625
Apr 201615166
May 2016121713
Jun 2016102011
Jul 2016122013
Aug 201619193
Sep 201614204
Oct 201653115
Nov 2016164625
Dec 201623424
Jan 201724023
Feb 201732723
Mar 201745923
Apr 201734520
May 201744225
Jun 201702619
Jul 201743212
Aug 201704522
Sep 201764513
Oct 201704120
Nov 201733423
Dec 201712610
Jan 201834027
Feb 201832917
Mar 2018104628
Apr 201817017
May 201828626
Jun 201835523
Jul 201863219
Aug 201823033
Sep 201843025
Oct 201833718
Nov 201855316
Dec 201841147
Jan 20196545
Feb 20193742
Mar 20194124
Apr 20194265
May 201951211
Jun 20194156
Jul 20191626
Aug 20194035
Sep 20192345
Oct 20195331
Nov 201953612
Dec 20194132
Jan 20203962
Feb 20202410
Mar 20206012
Apr 20203900
May 20201201
Jun 20202700
Jul 20202002
Aug 202013412
Sep 20203415
Oct 20201943
Nov 20203846
Dec 20203122
Jan 20213764
Feb 20212982
Mar 20213554
Apr 20213722
May 20213857
Jun 20212341
Jul 20211721
Aug 20212661
Sep 20215645
Oct 20214410
Nov 20212453
Dec 20212984
Jan 202225110
Feb 20223910
Mar 20222021
Apr 20223246
May 20222321
Jun 20223311
Jul 20224321
Aug 20223212
Sep 20224576
Oct 20223851
Nov 20222116
Dec 20224215
Jan 20235152
Feb 20231932
Mar 20233033
Apr 20233212
May 20233852
Jun 20232441
Jul 20232426
Aug 20232135
Sep 20232535
Oct 20231824
Nov 20233204
Dec 202380171
Jan 20245823
Feb 20243020
Mar 202435130
Apr 20242757
May 20244221
Jun 20242921
Jul 20243744
Aug 20244235
Sep 20244727
Oct 20244144
Nov 20245223
Dec 20243000

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticlePerspectives in Pharmacology

Cancer Therapy, Cardiotoxicity, and Ranolazine

Giorgio Minotti
Journal of Pharmacology and Experimental Therapeutics September 1, 2013, 346 (3) 343-349; DOI: https://doi.org/10.1124/jpet.113.204057
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement